Search - tctmd.com

Displaying 141 - 160 of 168

Sort: Relevancy | Date

DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions

News Conference News ACC 2017

DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions

Yael L. Maxwell

March 19, 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

March 18, 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

This Was Not Supposed to Happen!

Presentation SIF 2017

This Was Not Supposed to Happen!

Presenter: Douglas E. Drachman

March 10, 2017

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

March 10, 2017

Salvaging a Disaster: 78 yo Male prior CABG presents with Acute CHF

Presentation SIF 2017

Salvaging a Disaster: 78 yo Male prior CABG presents with Acute CHF

Presenter: Michael J. Rinaldi

March 10, 2017

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

News Daily News

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

March 10, 2017

PCI Pharmacology in 2017: Understanding the Essentials

Presentation SIF 2017

PCI Pharmacology in 2017: Understanding the Essentials

Presenter: MIchael A. Kutcher

March 09, 2017

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

News Daily News

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

March 07, 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

Presentation

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

February 13, 2017

New Oral Anticoagulants: Are the Best Options

Presentation

New Oral Anticoagulants: Are the Best Options

Presenter: Roberta Rossini

February 10, 2017

Intravenous P2Y12 Receptor Inhibitors: Now We Can Do It

Presentation JIM 2017

Intravenous P2Y12 Receptor Inhibitors: Now We Can Do It

Presenter: Dominick J. Angiolillo

February 10, 2017

Appendix Closure is the Solution

Presentation JIM 2017

Appendix Closure is the Solution

Presenter: Horst Sievert

February 10, 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Presentation JIM 2017

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Presenter: Giuseppe Tarantini

February 10, 2017

Rivaroxaban’s “Overwhelming” Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

February 08, 2017

10-Year Follow Up of Early DES Shows Steady Risk of Late Events

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

February 08, 2017

US Data Show Positive Trends in Cardiovascular Care, Though Opportunities for Progress Persist

News Daily News

US Data Show Positive Trends in Cardiovascular Care, Though Opportunities for Progress Persist

Yael L. Maxwell

January 23, 2017

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

January 19, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.